Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study

被引:3
|
作者
Makita, Kenji [1 ,2 ,3 ,5 ]
Hamamoto, Yasushi [1 ]
Kanzaki, Hiromitsu [1 ]
Nagasaki, Kei [1 ]
Kozuki, Toshiyuki [4 ]
机构
[1] Natl Hosp Org, Dept Radiat Oncol, Shikoku Canc Ctr, Matsuyama, Ehime 7910280, Japan
[2] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime 7910295, Japan
[3] Ehime Prefectural Cent Hosp, Dept Radiol, Matsuyama, Ehime 7900024, Japan
[4] Natl Hosp Org, Dept Thorac Oncol & Med, Shikoku Canc Ctr, Matsuyama, Ehime 7910280, Japan
[5] Natl Hosp Org, Shikoku Canc Ctr, Dept Radiat Oncol, Kou 160 Minami Umenomoto Machi, Matsuyama, Ehime 7910280, Japan
关键词
bone metastasis; lung cancer; palliative; radiotherapy; local control; TO-LYMPHOCYTE RATIO; RADIATION-THERAPY; SKELETAL METASTASES; ZOLEDRONIC ACID; CHEMOTHERAPY; INFLAMMATION; DENOSUMAB; SURVIVAL;
D O I
10.3892/ol.2023.13889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bone metastasis is common in advanced lung cancer, with the incidence reported to be 30%, and radiotherapy (RT) is used for pain relief from bone metastasis. The present study aimed to identify factors affecting local control (LC) of bone metastasis from lung cancer and to assess the significance of moderate RT dose escalation. This was a retrospective cohort study, where LC of bone metastasis from lung cancer that had received palliative RT was reviewed. LC at RT sites was evaluated with follow-up computed tomography (CT). The influence of treatment-, cancer- and patient-related risk factors for LC was assessed. A total of 317 metastatic lesions in 210 patients with lung cancer were evaluated. The median RT dose (biologically effective dose calculated using an alpha/beta of 10 Gy; BED10) was 39.0 Gy (range, 14.4-50.7 Gy). The median follow-up time for survival and median radiographic follow-up time were 8 (range, 1-127) and 4 (range, 1-124) months, respectively. The 0.5-year overall survival and LC rates were 58.9 and 87.7%, respectively. The local recurrence rate in RT sites was 11.0%, and bone metastatic progression, except in RT sites, was observed in 46.1% at the time of local recurrence or the last follow-up CT of the RT sites. According to multivariate analysis, RT sites, pre-RT neutrophil to lymphocyte ratio (NLR), post-RT non-administration of molecular-targeting agents (MTs), and non-administration of bone modifying agents (BMAs) were significant unfavorable factors for LC of bone metastasis. Moderate RT dose escalation (BED10 >39 Gy) tended to improve the LC of RT sites. In cases without MTs, moderate dose escalation of RT dose improved the LC of RT sites. In conclusion, treatment (post-RT MTs and BMAs), cancer (RT sites) and patient (pre-RT NLR)-related risk factors had a large impact on improving the LC of RT sites. Moderate RT dose escalation seemed to have a small impact on improving the LC of RT sites.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Role of Radiotherapy for Local Control of Asymptomatic Adrenal Metastasis From Lung Cancer
    Oshiro, Yoshiko
    Takeda, Yuichiro
    Hirano, Satoshi
    Ito, Hideyuki
    Aruga, Takashi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (03): : 249 - 253
  • [22] Upfront Radiotherapy in Patients With Asymptomatic Incurable Rectal Cancer:. Retrospective Cohort Study
    Jonsson, Gabriel
    Philipson, Louise
    Villman, Kenneth
    Valachis, Antonis
    ANTICANCER RESEARCH, 2020, 40 (10) : 5853 - 5860
  • [23] Sites of Synchronous Distant Metastases, Prognosis, and Nomogram for Small Cell Lung Cancer Patients with Bone Metastasis: A Large Cohort Retrospective Study
    Fan, Zhiyi
    Huang, Zhangheng
    Tong, Yuexin
    Zhu, Zhe
    Huang, Xiaohui
    Sun, He
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [24] Palliative radiotherapy for painful non-bone lesions in patients with advanced cancer: a single center retrospective study
    Shindo, Yurika
    Koide, Yutaro
    Nagai, Naoya
    Kitagawa, Tomoki
    Aoyama, Takahiro
    Shimizu, Hidetoshi
    Hashimoto, Shingo
    Tachibana, Hiroyuki
    Kodaira, Takeshi
    Ishihara, Shunichi
    Naganawa, Shinji
    JAPANESE JOURNAL OF RADIOLOGY, 2024, 42 (06) : 656 - 661
  • [25] Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study
    Jin Huang
    Elaine S Wai
    Francis Lau
    Paul A Blood
    BMC Palliative Care, 13
  • [26] Pulmonary complication of chemotherapy and radiotherapy in patients with lung cancer: a prospective cohort study
    AbdelRahman, Ahmed
    El-Helbawy, Rana
    Youssef, Maha
    Alagizy, Hager Abdel Megid
    Abu-Shady, Mustafa
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2018, 67 (04): : 435 - 441
  • [27] Recursive Partitioning Analysis Classification and Graded Prognostic Assessment for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospective Cohort Study
    Sun, Cai-xing
    Li, Tao
    Zheng, Xiao
    Cai, Ju-fen
    Meng, Xu-li
    Yang, Hong-jian
    Wang, Zheng
    CHINESE JOURNAL OF CANCER RESEARCH, 2011, 23 (03) : 177 - 182
  • [28] Radiotherapy of Bone Metastasis in Breast Cancer Patients - Current Approaches
    Feyer, Petra C.
    Steingraeber, Maria
    BREAST CARE, 2012, 7 (02) : 108 - 112
  • [29] Facing problems in radiotherapy for breast cancer patients in Yogyakarta, Indonesia: A cohort retrospective study
    Suryanegara, Fithria Dyah Ayu
    Rokhman, M. Rifqi
    Ekaputra, Ericko
    de Jong, Lisa Aniek
    Setiawan, Didik
    de Bock, Geertruida H.
    Postma, Maarten Jacobus
    CANCER MEDICINE, 2023, 12 (07): : 8851 - 8859
  • [30] Factors affecting survival after palliative radiotherapy in patients with lung cancer
    Aires, Fatima
    Rodrigues, Edna
    Marques, Margarida
    Pinto, Maria
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2021, 26 (05) : 674 - 682